Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:02:02 EDT Sat 18 May 2024
Enter Symbol
or Name
USA
CA



News for U:SNGX from 2023-05-18 to 2024-05-17 - 31 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-16 07:30U:SNGXNews ReleasePositive Clinical Results from HyBryte(TM) Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice
2024-05-10 07:30U:SNGXNews ReleaseSoligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results
2024-05-06 07:30U:SNGXNews ReleaseSoligenix to Present at Upcoming Conferences
2024-04-25 07:30U:SNGXNews ReleaseSoligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa
2024-04-18 08:30U:SNGXNews ReleaseSoligenix Announces Pricing of $4.75 Million Public Offering
2024-04-15 07:30U:SNGXNews ReleaseFDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
2024-04-11 07:30U:SNGXNews ReleaseFDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
2024-04-03 07:30U:SNGXNews ReleaseSoligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte(TM) With the European Medicines Agency
2024-03-15 07:30U:SNGXNews ReleaseSoligenix Announces Recent Accomplishments and Year End 2023 Financial Results
2024-02-08 07:30U:SNGXNews ReleaseSoligenix Announces Formation of Beh ƒ §et's Disease Medical Advisory Board
2024-01-26 09:01U:SNGXNews ReleaseSoligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
2024-01-25 07:30U:SNGXNews ReleaseSoligenix to Present at The Microcap Conference
2024-01-08 07:30U:SNGXNews ReleaseFDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Beh ƒ §et's Disease
2024-01-04 07:30U:SNGXNews ReleaseSoligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
2024-01-02 07:30U:SNGXNews ReleaseSoligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses
2023-12-01 07:30U:SNGXNews Release"HyBryte ¢ „ ¢ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery
2023-11-30 07:30U:SNGXNews ReleaseSoligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Beh ƒ §et's Disease
2023-11-17 16:00U:SNGXNews ReleaseSoligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
2023-11-13 07:30U:SNGXNews ReleaseSoligenix Announces Recent Accomplishments And Third Quarter 2023 Financial Results
2023-10-20 16:00U:SNGXNews ReleaseSoligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
2023-10-20 09:02U:SNGXNews ReleaseASP Isotopes and Soligenix Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
2023-10-16 07:30U:SNGXNews ReleaseSoligenix to Present at The ThinkEquity Conference
2023-10-13 09:01U:SNGXNews ReleaseSPI Energy and Soligenix Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
2023-10-06 09:03U:SNGXNews ReleaseKnightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
2023-09-25 07:30U:SNGXNews ReleaseSoligenix Announces Achievement of Two-Year Stability with Bivalent and Trivalent Thermostabilized Filovirus Vaccines when Stored at High Temperatures
2023-09-22 16:00U:SNGXNews ReleaseSoligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting and Additional Proposal to be Considered by Stockholders
2023-08-21 07:30U:SNGXNews ReleaseSoligenix Announces Recent Accomplishments And Second Quarter 2023 Financial Results
2023-08-11 10:09U:SNGXNews ReleaseBioVie and Soligenix Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
2023-08-10 07:30U:SNGXNews ReleaseHyBryte ¢ „ ¢ Expanded Treatment Trial in Cutaneous T-Cell Lymphoma Opens Enrollment
2023-07-11 07:30U:SNGXNews ReleaseSoligenix Announces Expansion of SGX302 (Synthetic Hypericin) Phase 2a Study in Mild-to-Moderate Psoriasis
2023-06-02 09:01U:SNGXNews ReleaseSoligenix, and Graphex Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)